stock
BCAX · Bicara Therapeutics Inc.
What Bicara Therapeutics Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live BCAX price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on BCAX.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 66,172,934 as of 2026-08-06 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- —
- Net
- —
Returns
- ROE
- -39.5%
- ROA
- -36.2%
Health
- Current ratio
- 11.6x
- Debt/equity
- —
Deep value
- NCAV
- $460.35M
- NCAV per share
- $6.96
- Price/NCAV
- Locked
- NNWC
- $53.12M
- NNWC per share
- $0.80
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue (not reported by this company) | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$59.95M | -$55.44M | 10-Q filed 2026-08-11 |
| 2026-03-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$60.24M | -$56.21M | 10-Q filed 2026-08-11 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$41.12M | -$37.39M | 10-K filed 2026-03-30 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2025-09-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$40.68M | -$36.33M | 10-Q filed 2025-11-10 |
| 2025-06-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$32.02M | -$27.39M | 10-Q filed 2026-08-11 |
| 2025-03-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$41.79M | -$36.85M | 10-Q filed 2026-08-11 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$26.64M | -$20.96M | 10-K filed 2026-03-30 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2024-09-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$20.63M | -$17.48M | 10-Q filed 2025-11-10 |
- Assets
- $512.24M
- Equity
- $468.77M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | — | -$155.60M | -$137.95M | -$107.11M |
| 2024-12-31 | — | -$82.39M | -$68.00M | -$74.82M |
| 2023-12-31 | — | -$39.89M | -$51.98M | -$46.21M |
Company filings
3 offering filings in 12 months · since Wed Feb 25
events
5% owners ()
JANUS HENDERSON GROUP Ltd.
Stake update
BlackRock, Inc.
Passive stake
Vestal Point Capital, LP
Stake update
JANUS HENDERSON GROUP PLC
Passive stake
Deep Track Capital, LP
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Cohlhepp Ryan
President, COO & Interim CEO, Director
Sale$400,716Sep 10, 4:23 PM ET
Hyep Ivan
Chief Financial Officer
Sale$349,591Aug 12, 4:19 PM ET
Mazumdar Claire
Chief Executive Officer, Director
Sale$279,750Aug 12, 4:19 PM ET
Cohlhepp Ryan
President and COO, Director
Sale$524,533Aug 12, 4:19 PM ET
Mazumdar Claire
Chief Executive Officer, Director
Sale$284,198Jul 14, 4:22 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
News
Stories that named BCAX, and the market events around them.
Sign in to see thisBoard
The BCAX board could not be loaded.
Retry the BCAX boardnakagai
Signals on BCAX come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the BCAX board